StockData
Geron Corp logo

Geron Corp (GERN) stock

GERNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 2/30
$0.91−0.08 (-7.86%)

Close on Nov 19, 2026Market cap $586.58MP/E –Yield –

Geron net income

Net income is the profit left for shareholders after every expense, interest and tax.

Geron's net income for the twelve months ending Jun 30, 2026 was -$67.61M. For fiscal 2025 it was -$83.50M. The highest annual figure on record is $46.00K in fiscal 2015.

Annual net income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$83.50M–
FY2024Dec 31, 2024-$174.57M–
FY2023Dec 31, 2023-$184.13M–
FY2022Dec 31, 2022-$141.90M–
FY2021Dec 31, 2021-$116.11M–
FY2020Dec 31, 2020-$75.62M–
FY2019Dec 31, 2019-$68.55M–
FY2018Dec 31, 2018-$27.02M–
FY2017Dec 31, 2017-$27.92M–
FY2016Dec 31, 2016-$29.54M-64310.9%
FY2015Dec 31, 2015$46.00K–
FY2014Dec 31, 2014-$35.67M–
FY2013Dec 31, 2013-$38.38M–
FY2012Dec 31, 2012-$68.88M–
FY2011Dec 31, 2011-$96.85M–
FY2010Dec 31, 2010-$111.38M–
FY2009Dec 31, 2009-$70.18M–

Quarterly net income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$16.68M–
Q1 FY2026Mar 31, 2026-$3.64M–
Q4 FY2025Dec 31, 2025-$28.86M–
Q3 FY2025Sep 30, 2025-$18.43M–
Q2 FY2025Jun 30, 2025-$16.38M–
Q1 FY2025Mar 31, 2025-$19.84M–
Q4 FY2024Dec 31, 2024-$25.35M–
Q3 FY2024Sep 30, 2024-$26.45M–
Q2 FY2024Jun 30, 2024-$67.38M–
Q1 FY2024Mar 31, 2024-$55.39M–
Q4 FY2023Dec 31, 2023-$51.97M–
Q3 FY2023Sep 30, 2023-$44.81M–
Q2 FY2023Jun 30, 2023-$49.23M–
Q1 FY2023Mar 31, 2023-$38.12M–
Q4 FY2022Dec 31, 2022-$42.64M–
Q3 FY2022Sep 30, 2022-$41.05M–
Q2 FY2022Jun 30, 2022-$28.12M–
Q1 FY2022Mar 31, 2022-$30.10M–
Q4 FY2021Dec 31, 2021-$32.02M–
Q3 FY2021Sep 30, 2021-$26.70M–
Q2 FY2021Jun 30, 2021-$29.57M–
Q1 FY2021Mar 31, 2021-$27.82M–
Q4 FY2020Dec 31, 2020-$23.79M–
Q3 FY2020Sep 30, 2020-$19.65M–
Q2 FY2020Jun 30, 2020-$15.82M–
Q1 FY2020Mar 31, 2020-$16.36M–
Q4 FY2019Dec 31, 2019-$29.07M–
Q3 FY2019Sep 30, 2019-$15.18M–
Q2 FY2019Jun 30, 2019-$14.24M–
Q1 FY2019Mar 31, 2019-$10.06M–
Q4 FY2018Dec 31, 2018-$7.30M–
Q3 FY2018Sep 30, 2018-$5.60M–
Q2 FY2018Jun 30, 2018-$6.93M–
Q1 FY2018Mar 31, 2018-$7.19M–
Q4 FY2017Dec 31, 2017-$7.43M–
Q3 FY2017Sep 30, 2017-$6.90M–
Q2 FY2017Jun 30, 2017-$6.41M–
Q1 FY2017Mar 31, 2017-$7.18M–
Q4 FY2016Dec 31, 2016-$8.48M–
Q3 FY2016Sep 30, 2016-$3.58M–

More Geron figures

See a number that looks wrong?